PubGene was awarded a new Eurostars project with start date July 2022 together with Da Vinci laboratory solution B.V., Erasmus MC and Evosep Aps.

Glioblastoma is a highly heterogeneous tumour and patients with this disease have a poor prognosis. Partly because the tumour infiltrates the surrounding brain tissue,

The futureofhealth.care is an online discussion platform for healthcare professionals. It identifies white space in the market so that promising start-up and healthcare industry

At PubGene AS, we are building Coremine Vitae, a new Digital Health solution for Personalized Medicine. Coremine Vitae empowers patients with cancer, autoimmune or

Join us on our mission to make personalized medicine available to all. At PubGene AS, we are building Coremine Vitae, a new Digital Health

Dr. Jimita Toraskar from PubGene AS was invited to participate in the International Lecture Series organized by Dr. Bhanuben Nanavati College of Pharmacy in

The futureofhealth.care is an online discussion platform for healthcare professionals. It identifies white space in the market so that promising start-up and healthcare industry

PubGene’s digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, ensuring that it complies with all the relevant Essential Requirements of the Medical

Innovation Norway – the State and the county authorities’ instrument for achieving value-creating business development – has allocated pre-project funds to PubGene to investigate how COREMINE Medical can be used